301 results found. Viewing page 52 of 61.
Go to page . . . . . .
The office of Continuing Medical Education at the David Geffen School of Medicine at UCLA and The Pacific Meso Center at the Pacific Heart, Lung & Blood Institute is holding the 3rd International Symposium on Lung-Sparing Therapies for Malignant ...
Continue Reading...
On February 13, 2013, Pacific Meso Center officially opened their new research laboratory whose sole focus will be on the development of innovative therapies and treatment for malignant pleural mesothelioma (MPM). This lab is the first free-standing ...
Continue Reading...
The question of whether extrapleural pneumonectomy (EPP) is superior to supportive care, in terms of morbidity, symptom control and survival, in the treatment of patients with malignant pleural mesothelioma (MPM) is examined by reviewing 14 papers ...
Continue Reading...
Although historically, extrapleural pneumonectomy (EPP) was the preferred surgical approach to the management of malignant pleural mesothelioma (MPM), physician and patient preferences have contributed to an increased number of lung-sparing ...
Continue Reading...
There is no doubt that malignant pleural mesothelioma (MPM) needs better non-invasive and accurate prognostication (the ability to predict medical outcomes of a treatment or disease) for several reasons, including but not limited to the following: a ...
Continue Reading...
301 results found. Viewing page 52 of 61.
Go to page . . . . . .